The Food and Drug Administration on Tuesday announced that a new warning of the serious adverse outc...

A study published today in JAMA Internal Medicine suggests that phone-based cognitive-behavioral the...

A form of cognitive-behavioral therapy especially developed to treat insomnia (CBT-I) was found to b...

A new surveillance study has found that benzodiazepine usage increases with age, with nearly 9 perce...

Last week, the Food and Drug Administration (FDA) approved Belsomra (suvoraxant) to treat individual...

The Food and Drug Administration has advised Merck Pharmaceuticals that suvorexant, the company’s in...

A Food and Drug Administration (FDA) advisory committee has decided that Merck's experimental drug s...

New research provides another reason why it is important to treat insomnia. It appears to be associa...

The Food and Drug Administration (FDA) announced that it is requiring manufacturers of widely used s...